Sotera Health Company (SHC)
NASDAQ: SHC · Real-Time Price · USD
15.74
-0.02 (-0.13%)
At close: Aug 15, 2025, 4:00 PM
15.49
-0.25 (-1.59%)
After-hours: Aug 15, 2025, 5:14 PM EDT
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
Sterigenics | 697.85M | Log In | Log In | Log In | Log In | Upgrade |
Sterigenics Growth | 5.29% | Log In | Log In | Log In | Log In | Upgrade |
Nordion | 173.36M | Log In | Log In | Log In | Log In | Upgrade |
Nordion Growth | -1.13% | Log In | Log In | Log In | Log In | Upgrade |
Nelson Labs | 229.23M | Log In | Log In | Log In | Log In | Upgrade |
Nelson Labs Growth | -3.35% | Log In | Log In | Log In | Log In | Upgrade |
Service | 941.82M | Log In | Log In | Log In | Log In | Upgrade |
Service Growth | 3.17% | Log In | Log In | Log In | Log In | Upgrade |
Product | 158.62M | Log In | Log In | Log In | Log In | Upgrade |
Product Growth | -1.86% | Log In | Log In | Log In | Log In | Upgrade |
Capex by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
Sterigenics Capital Expenditures | 131.26M | Log In | Log In | Log In | Log In | Upgrade |
Sterigenics Capital Expenditures Growth | -36.22% | Log In | Log In | Log In | Log In | Upgrade |
Nordion Capital Expenditures | 34.93M | Log In | Log In | Log In | Log In | Upgrade |
Nordion Capital Expenditures Growth | -12.13% | Log In | Log In | Log In | Log In | Upgrade |
Nelson Labs Capital Expenditures | 12.88M | Log In | Log In | Log In | Log In | Upgrade |
Nelson Labs Capital Expenditures Growth | 106.89% | Log In | Log In | Log In | Log In | Upgrade |
EBITDA by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
Sterigenics Segment Income | 378.17M | Log In | Log In | Log In | Log In | Upgrade |
Sterigenics Segment Income Growth | 5.62% | Log In | Log In | Log In | Log In | Upgrade |
Nordion Segment Income | 101.22M | Log In | Log In | Log In | Log In | Upgrade |
Nordion Segment Income Growth | -3.28% | Log In | Log In | Log In | Log In | Upgrade |
Nelson Labs Segment Income | 69.18M | Log In | Log In | Log In | Log In | Upgrade |
Nelson Labs Segment Income Growth | 6.40% | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
United States | 616.68M | Log In | Log In | Log In | Log In | Upgrade |
United States Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Canada | 208.89M | Log In | Log In | Log In | Log In | Upgrade |
Canada Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Europe | 196.01M | Log In | Log In | Log In | Log In | Upgrade |
Europe Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other Geographic | 78.86M | Log In | Log In | Log In | Log In | Upgrade |
Other Geographic Growth | - | Log In | Log In | Log In | Log In | Upgrade |